Zymeworks (ZYME) Profit After Tax (2021 - 2026)
Zymeworks (ZYME) reported Profit After Tax of -$486000.0 for Q1 2026, up 97.8% on a YoY basis from -$245702.8 in Q1 2025, and up 99.41% sequentially from -$82.0 million in Q4 2025.
Zymeworks (ZYME) Profit After Tax (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Profit After Tax data on file, last reported at -$486000.0 in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 97.8% year-over-year to -$486000.0; the trailing twelve-month figure through Mar 2026 stood at -$102.1 million (up 29.14% YoY), and the FY2025 full-year result was -$81.1 million, up 34.06% from the prior year.
- Profit After Tax climbed to -$486000.0 in Q1 2026, from -$82.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $309.4 million in Q4 2022 to a low of -$123.6 million in Q4 2024.
- A 5-year average of -$12.1 million and a median of -$1.5 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax soared 492.78% in 2024 and sank 1870.56% in 2025, its largest moves.
- Tracing ZYME's Profit After Tax over 5 years: stood at $309.4 million in 2022, then sank by 137.82% to -$117.0 million in 2023, then declined by 5.65% to -$123.6 million in 2024, then surged by 33.66% to -$82.0 million in 2025, then surged by 99.41% to -$486000.0 in 2026.
- Business Quant data shows ZYME's Profit After Tax at -$486000.0 in Q1 2026, -$82.0 million in Q4 2025, and -$19.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -486,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -486,000.00 |
| Dec 31, 2025 | -82.03 Mn |
| Sep 30, 2025 | -19.60 Mn |
| Jun 30, 2025 | 66,000.00 |
| Mar 31, 2025 | -22.09 Mn |
| Dec 31, 2024 | -123.65 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | -180,000.00 |
| Mar 31, 2024 | -1.12 Mn |
| Dec 31, 2023 | -117.04 Mn |
| Sep 30, 2023 | -485,000.00 |
| Jun 30, 2023 | -1.87 Mn |
| Mar 31, 2023 | 720,000.00 |
| Dec 31, 2022 | 309.43 Mn |
| Jun 30, 2022 | -64.62 Mn |
| Mar 31, 2022 | -72.63 Mn |
| Dec 31, 2021 | 172.69 Mn |
| Sep 30, 2021 | -60.58 Mn |